A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.

Saved in:
Bibliographic Details
Title: A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.
Authors: Wenham RM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA. Electronic address: robert.wenham@moffitt.org., Buras AL; Salem Health, Gynecologic Oncology, Salem, OR, USA., Gordon SW; Sidney Kimmel Comprehensive Cancer Center, Division of Hematology and Oncology, Thomas Jefferson University, Philadelphia, PA, USA; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA., Whiting J; Moffitt Cancer Center, Department of Biostatistics & Bioinformatics, Tampa, FL, USA., Fridley BL; Children's Mercy Kansas City, Division of Health Services and Outcomes Research, Kansas City, MO, USA., Dorman D; Clinical Trials Office, Moffitt Cancer Center, Tampa, FL, USA., Apte SM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Chon HS; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Shahzad MM; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA., Randall LM; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA; Inova Health System, Gynecologic Oncology Women's Service Line, Fairfax, VA, USA., Havrilesky LJ; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Davidson BA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute., Secord AA; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute.
Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Jun; Vol. 36 (6), pp. 102856. Date of Electronic Publication: 2025 Dec 13.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41558878
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wenham+RM%22">Wenham RM</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA. Electronic address: robert.wenham@moffitt.org.<br /><searchLink fieldCode="AU" term="%22Buras+AL%22">Buras AL</searchLink>; Salem Health, Gynecologic Oncology, Salem, OR, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+SW%22">Gordon SW</searchLink>; Sidney Kimmel Comprehensive Cancer Center, Division of Hematology and Oncology, Thomas Jefferson University, Philadelphia, PA, USA; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA.<br /><searchLink fieldCode="AU" term="%22Whiting+J%22">Whiting J</searchLink>; Moffitt Cancer Center, Department of Biostatistics & Bioinformatics, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Fridley+BL%22">Fridley BL</searchLink>; Children's Mercy Kansas City, Division of Health Services and Outcomes Research, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Dorman+D%22">Dorman D</searchLink>; Clinical Trials Office, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Apte+SM%22">Apte SM</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Chon+HS%22">Chon HS</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Shahzad+MM%22">Shahzad MM</searchLink>; Moffitt Cancer Center, Department of Gynecologic Oncology, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Randall+LM%22">Randall LM</searchLink>; Massey Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA, USA; Inova Health System, Gynecologic Oncology Women's Service Line, Fairfax, VA, USA.<br /><searchLink fieldCode="AU" term="%22Havrilesky+LJ%22">Havrilesky LJ</searchLink>; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Davidson+BA%22">Davidson BA</searchLink>; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Secord+AA%22">Secord AA</searchLink>; Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111626%22">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</searchLink> [Int J Gynecol Cancer] 2026 Jun; Vol. 36 (6), pp. 102856. <i>Date of Electronic Publication: </i>2025 Dec 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ%22">BMJ </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9111626 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-1438 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221048891X%22">1048891X </searchLink><i>NLM ISO Abbreviation: </i>Int J Gynecol Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41558878
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijgc.2025.102856
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102856
    Titles:
      – TitleFull: A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wenham RM
      – PersonEntity:
          Name:
            NameFull: Buras AL
      – PersonEntity:
          Name:
            NameFull: Gordon SW
      – PersonEntity:
          Name:
            NameFull: Whiting J
      – PersonEntity:
          Name:
            NameFull: Fridley BL
      – PersonEntity:
          Name:
            NameFull: Dorman D
      – PersonEntity:
          Name:
            NameFull: Apte SM
      – PersonEntity:
          Name:
            NameFull: Chon HS
      – PersonEntity:
          Name:
            NameFull: Shahzad MM
      – PersonEntity:
          Name:
            NameFull: Randall LM
      – PersonEntity:
          Name:
            NameFull: Havrilesky LJ
      – PersonEntity:
          Name:
            NameFull: Davidson BA
      – PersonEntity:
          Name:
            NameFull: Secord AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1525-1438
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
              Type: main
ResultId 1